Hyperlipidaemia as a complication of rifampicin treatment.
D000410:Alanine Transaminase / Q000097:blood; D000437:Alcoholism / Q000097:blood; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000097:blood; D002784:Cholesterol / Q000097:blood; D002914:Chylomicrons / Q000097:blood; D004359:Drug Therapy, Combination; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000139:chemically induced*; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000009:adverse effects* / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D000636:Aminosalicylic Acids; D002914:Chylomicrons; D005230:Fatty Acids, Nonesterified; D014280:Triglycerides; D002784:Cholesterol; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D007538:Isoniazid; D012293:Rifampin